We subsequently compared the prognostic accuracy of gankyrin and STAT3 or CCL24 with that of established indicators, namely, the TNM stage and SSIGN score, in predicting the prognosis of ccRCC patients. This evidence concerns the gene STAT3 and nonpapillary renal cell carcinoma.